About Mammoth Biosciences
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to improve lives by reading and writing the code of life. Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, Cas14, and CasΦ, Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.
Leadership at Mammoth Biosciences
The team at the top of the org chart.
Trevor Martin
Co-Founder & CEO
51 reports
Lucas Harrington
Cofounder & CSO
26 reports
Janice Chen
Co-founder, CSO & President, Research
8 reports
Elaine Sun
CFO & Chief Operating Officer
6 reports
Rachel Herder
SVP, Legal and Alliance Management (Head of IP)
3 reports
Jeanne G.
Director, People
2 reports
Phil Tinmouth
Chief Business Officer
Board
Dinah Sah
Scientific Advisor
Charles Albright
Board Member
Amrit Nagpal
Board Member
Jeff Huber
Chair
Maneesh Jain
Board Member
Jennifer Doudna
Co-Founder & Chair, Scientific Advisory Board